P

Inventor

GAO QI

NL50 patents
⚠️ This page may combine multiple inventors who share the name “GAO QI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

11 patents
US7851476B2Dec 14, 2010

Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine

BRISTOL MYERS SQUIBB CO16 citations79
US9156812B2Oct 13, 2015

Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine

BRISTOL MYERS SQUIBB CO3 citations61
US5284866AFeb 8, 1994

1H-cycloundeca[1,2-b:5,6-b']biscyclohepta(b)pyrans useful as antitumor agents

BRISTOL MYERS SQUIBB CO2 citations61
US7723338B2May 25, 2010

Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine

BRISTOL MYERS SQUIBB CO5 citations60
US7601715B2Oct 13, 2009

Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein

BRISTOL MYERS SQUIBB CO4 citations58
US9498476B2Nov 22, 2016

Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine

BRISTOL MYERS SQUIBB CO0 citations51
US9173879B2Nov 3, 2015

Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof

BRISTOL MYERS SQUIBB CO0 citations51
US7829711B2Nov 9, 2010

Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione

BRISTOL MYERS SQUIBB CO0 citations51
US5622863AApr 22, 1997

Culture of Eupenicillium brefeldianum

BRISTOL MYERS SQUIBB CO0 citations50
US7968718B2Jun 28, 2011

Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein

BRISTOL MYERS SQUIBB CO0 citations48
US9518058B2Dec 13, 2016

Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide

BRISTOL MYERS SQUIBB CO0 citations35

KONINKLIJKE PHILIPS NV

6 patents

VMWARE INC

4 patents

APPLIED MATERIALS INC

3 patents

SPH XING LING SCI & TECH PHARMACEUTICAL CO LTD

3 patents

SHANGHAI XINGLING SCI & TECH P

2 patents

OUR UNITED CORP

2 patents

CRRC NANJING PUZHEN CO LTD

2 patents

MOTOROLA INC

1 patent

SHANGHAI INST MATERIA MEDICA

1 patent

QIU JUN

1 patent

GAO QI

1 patent

PLIANT THERAPEUTICS INC

1 patent

KIM SOOJIN

1 patent

SHENZHEN OUR NEW MEDICAL TECH DEVELOPMENT CO LTD

1 patent

MITSUBISHI CHEM CORP

1 patent

OPTISIGNS INC

1 patent

HEFEI XINSHENG OPTOELECTRONICS TECHNOLOGY CO LTD

1 patent

VARIAN SEMICONDUCTOR EQUIPMENT ASS INC

1 patent

BOE TECHNOLOGY GROUP CO LTD

1 patent

SU LIFENG

1 patent

HONOR DEVICE CO LTD

1 patent

WEI CHENKOU

1 patent

UNIV TSINGHUA

1 patent

NANYANG EDIBLE FUNGUS TECH EXCHANGE CENTER (GENERAL PARTNERSHIP)

1 patent